These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Using clinical data to determine vancomycin dosing parameters. Birt JK; Chandler MH Ther Drug Monit; 1990 Mar; 12(2):206-9. PubMed ID: 2315979 [TBL] [Abstract][Full Text] [Related]
8. The appropriateness of initial vancomycin dosing. Rodman DP; McKnight JT; Rogers T; Robbins M J Fam Pract; 1994 May; 38(5):473-7. PubMed ID: 8176345 [TBL] [Abstract][Full Text] [Related]
9. Allometric versus consensus guideline dosing in achieving target vancomycin trough concentrations. Brown ML; Hutchison AM; McAtee AM; Gaillard PR; Childress DT Am J Health Syst Pharm; 2017 Jul; 74(14):1067-1075. PubMed ID: 28522643 [TBL] [Abstract][Full Text] [Related]
10. Vancomycin Dosing and Monitoring: Critical Evaluation of the Current Practice. Elbarbry F Eur J Drug Metab Pharmacokinet; 2018 Jun; 43(3):259-268. PubMed ID: 29260505 [TBL] [Abstract][Full Text] [Related]
11. Vancomycin Dosing in Obese Patients: Special Considerations and Novel Dosing Strategies. Durand C; Bylo M; Howard B; Belliveau P Ann Pharmacother; 2018 Jun; 52(6):580-590. PubMed ID: 29262697 [TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion. Waineo MF; Kuhn TC; Brown DL J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426 [TBL] [Abstract][Full Text] [Related]
13. Performance of a divided-load intravenous vancomycin dosing strategy for obese patients. Denetclaw TH; Yu MK; Moua M; Dowling TC; Steinke D Ann Pharmacother; 2015 Aug; 49(8):861-8. PubMed ID: 25986008 [TBL] [Abstract][Full Text] [Related]
14. Weight-based versus set dosing of vancomycin for coronary artery bypass grafting or aortic valve surgery. Hafermann MJ; Kiser TH; Lyda C; Fish DN; Barber GR; Wempe MF; Cleveland JC J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1925-30. PubMed ID: 24521953 [TBL] [Abstract][Full Text] [Related]
15. AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug. Brown DL; Lalla CD; Masselink AJ Ther Drug Monit; 2013 Aug; 35(4):443-9. PubMed ID: 23851909 [TBL] [Abstract][Full Text] [Related]
16. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data]. Xu G; Chen E; Mao E; Che Z; He J Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790 [TBL] [Abstract][Full Text] [Related]
17. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring. Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142 [TBL] [Abstract][Full Text] [Related]
18. Vancomycin dosing in children and young adults: back to the drawing board. Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205 [TBL] [Abstract][Full Text] [Related]
19. Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling. Janssen EJ; Välitalo PA; Allegaert K; de Cock RF; Simons SH; Sherwin CM; Mouton JW; van den Anker JN; Knibbe CA Antimicrob Agents Chemother; 2016 Feb; 60(2):1013-21. PubMed ID: 26643337 [TBL] [Abstract][Full Text] [Related]
20. Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing. Neely MN; Kato L; Youn G; Kraler L; Bayard D; van Guilder M; Schumitzky A; Yamada W; Jones B; Minejima E Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]